You are here: Industry Insights > molecule

News List

Promising molecule for treatment of COVID-19 WorldPharmaNews
February 11, 2022
Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19.
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines WorldPharmaNews
January 21, 2022
Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology...
Sanofi and Exscientia to develop AI-driven cancer and immunology medicines Pharmaceutical-Technology
January 11, 2022
Sanofi and Exscientia have entered a research partnership and licence agreement for the development of up to 15 new small-molecule medicines across oncology and immunology.
Exscientia and Sanofi establish research collaboration to develop AI-driven precision engineered medicines ExpressPharma
January 10, 2022
Sanofi and Exscientia recently announced a research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology...
Are scientists homing in on a cure for Parkinson’s disease? WorldPharmaNews
December 13, 2021
A molecule that shows promise in preventing Parkinson’s disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
US researchers identify tiny molecule to neutralise Covid-19 virus pharmaceutical-technology
September 17, 2020
A research team at the University of Pittsburgh School of Medicine in the US has isolated a tiny biological molecule that could completely neutralise SARS-CoV-2, the virus that causes Covid-19.
Shiv Nadar University develops molecule with potential to cure COVID-19 expresspharma
April 29, 2020
The molecule has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients, animal trials to begin soon as a prelude to human trials.
Small molecules dominate FDA drug approvals this month europeanpharmaceuticalreview
September 02, 2019
This August saw nine new green lights from the FDA, all small molecules, which makes up a third of the approvals this year.
Northern Antibiotics develops new drug for resistant bacteria pharmaceutical-technology
August 22, 2019
Finnish virtual antibiotics developer Northern Antibiotics is working towards a new molecule that targets drug-resistant bacteria.
Skyhawk, Genentech Enter Exclusive Multi-target RNA Alliance contractpharma
July 17, 2019
Will leverage SkySTAR platform to discover and develop small molecule treatments for oncology and neurological disease targets.

Previous page 1 2 Next page